UK
Danmark
Deutschland
Global English
US
España
Suomi
France
Bélgique (FR)
Italia
Nederland
Norge
Sverige
Skin fold problems & successful long term management through cleaning
Meet Nextview – Nextmune’s new customer portal
...
Dr. Thierry Olivry's Point of View | December 2020
Continuing allergen immunotherapy for longer than one year should lead to a higher treatment success! To ensure the...
The future of IgE sensitisation detection - PAX® NOW AVAILABLE
From today, PAX® is officially available for the testing of dog sera....
Dr. Thierry Olivry's Point of View | October 2020
Can I perform IgE serology or intradermal testing when my patient is treated with glucocorticoids, cyclosporine,...
CCDs & Their Role in Allergy Diagnostics
What are CCDs? Carbohydrate Cross-Reactive Determinants (CCDs) are protein-linked carbohydrate structures responsible...
Nextmune enters partnership with biotechnology company Angany Inc.
Nextmune has signed an agreement to develop new vaccines for allergy and atopic dermatitis together with Angany, a...
Dr. Thierry Olivry joins Nextmune
Welcome to the team, Dr. Thierry Olivry! We are delighted to announce Dr. Thierry Olivry has joined our company as a...
Dr. Thierry Olivry's Point of View | January 2021
What should I choose: intradermal testing or IgE serology? Dear Colleagues,...
All posts